Suparma Tbk PT
IDX:SPMA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intrinsic Value
PT Suparma Tbk engages in the manufacture and sale of paper and its related products. [ Read More ]
The intrinsic value of one SPMA stock under the Base Case scenario is 626.49 IDR. Compared to the current market price of 284 IDR, Suparma Tbk PT is Undervalued by 55%.
Valuation Backtest
Suparma Tbk PT
Run backtest to discover the historical profit from buying and selling SPMA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Suparma Tbk PT
Current Assets | 1.3T |
Cash & Short-Term Investments | 279.3B |
Receivables | 226.7B |
Other Current Assets | 814.2B |
Non-Current Assets | 1.9T |
Long-Term Investments | 29.9B |
PP&E | 1.9T |
Other Non-Current Assets | 15.9B |
Current Liabilities | 396.7B |
Accounts Payable | 119B |
Accrued Liabilities | 18B |
Short-Term Debt | 5.6B |
Other Current Liabilities | 254.1B |
Non-Current Liabilities | 500.9B |
Long-Term Debt | 260.1B |
Other Non-Current Liabilities | 240.8B |
Earnings Waterfall
Suparma Tbk PT
Revenue
|
2.6T
IDR
|
Cost of Revenue
|
-2.2T
IDR
|
Gross Profit
|
451.3B
IDR
|
Operating Expenses
|
-215.6B
IDR
|
Operating Income
|
235.7B
IDR
|
Other Expenses
|
-115.3B
IDR
|
Net Income
|
120.3B
IDR
|
Free Cash Flow Analysis
Suparma Tbk PT
IDR | |
Free Cash Flow | IDR |
SPMA Profitability Score
Profitability Due Diligence
Suparma Tbk PT's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Suparma Tbk PT's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
SPMA Solvency Score
Solvency Due Diligence
Suparma Tbk PT's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Suparma Tbk PT's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SPMA Price Targets Summary
Suparma Tbk PT
Shareholder Return
SPMA Price
Suparma Tbk PT
Average Annual Return | 49.15% |
Standard Deviation of Annual Returns | 111.96% |
Max Drawdown | -62% |
Market Capitalization | 895.8B IDR |
Shares Outstanding | 3 154 089 984 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Suparma Tbk engages in the manufacture and sale of paper and its related products. The company is headquartered in Surabaya, Jawa Timur and currently employs 779 full-time employees. The firm is engaged in the producing of quality paper and packaging paper products, which can be classified into two types: industrial and consumer. Its industrial paper products include duplex board, wrapping kraft, ribbed kraft, laminated kraft, samson kraft, base paper, and machine glazed paper. Its consumer paper products include tissue paper, towel paper, laminated wrapping craft, and laminated machine glazed paper. Its products are marketed under two brand names See-U and Plenty. The firm sells its products domestically and internationally.
Contact
IPO
Employees
Officers
The intrinsic value of one SPMA stock under the Base Case scenario is 626.49 IDR.
Compared to the current market price of 284 IDR, Suparma Tbk PT is Undervalued by 55%.